These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8336334)

  • 1. Synthesis and anticonvulsant activity of enaminones. 2. Further structure-activity correlations.
    Scott KR; Edafiogho IO; Richardson EL; Farrar VA; Moore JA; Tietz EI; Hinko CN; Chang H; el-Assadi A; Nicholson JM
    J Med Chem; 1993 Jul; 36(14):1947-55. PubMed ID: 8336334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and anticonvulsant activity of enaminones. Part 6: Synthesis of substituted vinylic benzamides as potential anticonvulsants.
    Foster JE; Nicholson JM; Butcher R; Stables JP; Edafiogho IO; Goodwin AM; Henson MC; Smith CA; Scott KR
    Bioorg Med Chem; 1999 Nov; 7(11):2415-25. PubMed ID: 10632051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anticonvulsant activity of enaminones.
    Edafiogho IO; Hinko CN; Chang H; Moore JA; Mulzac D; Nicholson JM; Scott KR
    J Med Chem; 1992 Jul; 35(15):2798-805. PubMed ID: 1495012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of anticonvulsant activity and minimal toxicity of methyl 4-[(p-chlorophenyl)amino]-6-methyl-2-oxo-cyclohex-3-en-1-oate and some prototype antiepileptic drugs in mice and rats.
    Mulzac D; Scott KR
    Epilepsia; 1993; 34(6):1141-6. PubMed ID: 8243370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant evaluation and mechanism of action of benzylamino enaminones.
    Edafiogho IO; Ananthalakshmi KV; Kombian SB
    Bioorg Med Chem; 2006 Aug; 14(15):5266-72. PubMed ID: 16621576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anticonvulsant activity of enaminones. Part 7. Synthesis and anticonvulsant evaluation of ethyl 4-[(substituted phenyl)amino]-6-methyl-2-oxocyclohex-3-ene-1-carboxylates and their corresponding 5-methylcyclohex-2-enone derivatives.
    Eddington ND; Cox DS; Khurana M; Salama NN; Stables JP; Harrison SJ; Negussie A; Taylor RS; Tran UQ; Moore JA; Barrow JC; Scott KR
    Eur J Med Chem; 2003 Jan; 38(1):49-64. PubMed ID: 12593916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and anticonvulsant evaluation of fluorinated benzyl amino enaminones.
    Apraku J; Okoro CO
    Bioorg Med Chem; 2019 Jan; 27(1):161-166. PubMed ID: 30503782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, and anticonvulsant activity of enaminones. Part 5: investigations on 3-carboalkoxy-2-methyl-2,3-dihydro-1H-phenothizin-4[10H]-one derivatives.
    Laws ML; Roberts RR; Nicholson JM; Butcher R; Stables JP; Goodwin AM; Smith CA; Scott KR
    Bioorg Med Chem; 1998 Dec; 6(12):2289-99. PubMed ID: 9925291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.
    Kamiński K; Rapacz A; Łuszczki JJ; Latacz G; Obniska J; Kieć-Kononowicz K; Filipek B
    Bioorg Med Chem; 2015 May; 23(10):2548-61. PubMed ID: 25868743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 2,6-dicarbethoxy-3,5-diaryltetrahydro-1,4-thiazine-1,1-dioxide derivatives as potent anticonvulsant agents.
    Edayadulla N; Ramesh P
    Eur J Med Chem; 2015 Dec; 106():44-9. PubMed ID: 26519928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticonvulsant activities of N-Benzyl-2-acetamidopropionamide derivatives.
    Choi D; Stables JP; Kohn H
    J Med Chem; 1996 Apr; 39(9):1907-16. PubMed ID: 8627614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
    He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
    Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant and neurotoxicity evaluation of some 6-chlorobenzothiazolyl-2-thiosemicarbazones.
    Yogeeswari P; Sriram D; Sunil Jit LR; Kumar SS; Stables JP
    Eur J Med Chem; 2002 Mar; 37(3):231-6. PubMed ID: 11900867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant and neurotoxicity evaluation of some novel kojic acids and allomaltol derivatives.
    Aytemir MD; Calis U
    Arch Pharm (Weinheim); 2010 Mar; 343(3):173-81. PubMed ID: 20108269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration-dependent effects of anticonvulsant enaminone methyl 4-(4'-bromophenyl)aminocyclohex-3-en-6-methyl-2-oxo-1-oate on neuronal excitability in vitro.
    Ananthalakshmi KV; Edafiogho IO; Kombian SB
    Neuroscience; 2006 Aug; 141(1):345-56. PubMed ID: 16650601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
    Gunia-Krzyżak A; Żelaszczyk D; Rapacz A; Żesławska E; Waszkielewicz AM; Pańczyk K; Słoczyńska K; Pękala E; Nitek W; Filipek B; Marona H
    Bioorg Med Chem; 2017 Jan; 25(2):471-482. PubMed ID: 27876250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Synthesis of 5-Substituted Benzo[d][1,3]dioxole Derivatives as Potent Anticonvulsant Agents.
    Dong S; Wang T; Hu C; Chen X; Jin Y; Wang Z
    Arch Pharm (Weinheim); 2017 Feb; 350(2):. PubMed ID: 28092111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis of 6-substituted-pyrido[3,2-d]pyridazine derivatives with anticonvulsant activity.
    Dong ZQ; Liu XM; Wei CX; Quan ZS
    Med Chem; 2015; 11(6):595-601. PubMed ID: 25770755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant enaminones depress excitatory synaptic transmission in the rat brain by enhancing extracellular GABA levels.
    Kombian SB; Edafiogho IO; Ananthalakshmi KV
    Br J Pharmacol; 2005 Aug; 145(7):945-53. PubMed ID: 15912138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.